Interferons. New additions and indications for use.
Within the past few years, natural and recombinant cytokines have become available for clinical use. The broadest clinical experience exists with the interferons because these were available first. This article discusses the clinical efficiency and therapeutic value of natural and recombinant interferon-alpha, -beta, and -gamma, alone or as part of a combination therapy of skin disorders. A novel therapeutic schedule for skin tumors such as cutaneous T-cell lymphoma and malignant melanoma and for some inflammatory skin disorders are proposed.
Stadler
R
R
Department of Dermatology, Minden's Medical Center, Germany.
Ruszczak
Z
Z
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000628:therapy; D000818:Animals; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D016899:Interferon-beta / Q000627:therapeutic use; D007371:Interferon-gamma / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use*; D012514:Sarcoma, Kaposi / Q000209:etiology / Q000628:therapy; D012871:Skin Diseases / Q000150:complications / Q000628:therapy*; D017193:Skin Diseases, Viral / Q000628:therapy; D012878:Skin Neoplasms / Q000209:etiology / Q000628:therapy*
D016898:Interferon-alpha; D016899:Interferon-beta; D007371:Interferon-gamma; D007372:Interferons